Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)-Reference-Cited by-同舟云学术

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Published:2014-04 Issue:13 Volume:63 Page:1278-1288
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Raal Frederick J.,Giugliano Robert P.,Sabatine Marc S.,Koren Michael J.,Langslet Gisle,Bays Harold,Blom Dirk,Eriksson Mats,Dent Ricardo,Wasserman Scott M.,Huang Fannie,Xue Allen,Albizem Moetaz,Scott Rob,Stein Evan A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. The mysteries of lipoprotein(a);Utermann;Science,1989

2. The recurring evolution of lipoprotein(a). Insights from cloning of hedgehog apolipoprotein(a);Lawn;J Biol Chem,1995

3. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data;Bennet;Arch Intern Med,2008

4. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction;Kamstrup;JAMA,2009

5. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality;Erqou;JAMA,2009

Cited by 315 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive retrospect on biomarkers indicating vascular failure;Vascular Failure;2024-12-01

2. Lipoprotein(a): Are we ready for large-scale clinical trials?;International Journal of Cardiology;2024-09

3. Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review;International Journal of Molecular Sciences;2024-08-13

4. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

5. Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor;European Heart Journal;2024-03-04